Showing results (261-270 of 447) with videos related to

Sort By:
Pageof 45
Carcinogenesis|January 1, 2013
Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancerDong-Liang Chen, De-Shen Wang, Wen-Jing Wu, et al.
BMC Cancer|May 3, 2015
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratioXiao-li Wei, Feng-hua Wang, Dong-sheng Zhang, et al.
Therapeutic Advances in Medical Oncology|January 11, 2024
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancerZi-Yao Huang, Lei Wen, Liu-Fang Ye, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 25, 2003
[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
Cancer Management and Research|May 24, 2019
Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patientsRui Gong, Yuan He, Xiao-Yun Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 12, 2014
Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observationMiao-zhen Qiu, Xiao-li Wei, Dong-sheng Zhang, et al.
Zhonghua Nei Ke Za Zhi|May 16, 2008
[A survival of 103 cases of T-cell non-Hodgkin lymphoma]Yan-Xia Shi, Rou-Jun Peng, Su-Xia Lin, et al.
The Lancet. Oncology|November 7, 2017
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trialYung-Jue Bang, Rui-Hua Xu, Keisho Chin, et al.
Chinese Journal of Cancer|October 1, 2011
Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trialZhong-Zhen Guan, Jian-Ming Xu, Rong-Cheng Luo, et al.
Cancer Science|October 4, 2018
Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancerMing-Ming He, Feng Wang, Ying Jin, et al.
Pageof 45